File(s) not publicly available
Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity
Version 2 2024-06-19, 10:19Version 2 2024-06-19, 10:19
Version 1 2022-03-31, 12:14Version 1 2022-03-31, 12:14
journal contribution
posted on 2005-08-01, 00:00 authored by S J E Beavitt, K W Harder, J M Kemp, J Jones, C Quilici, F Casagranda, E Lam, D Turner, S Brennan, Peter Sly, D M Tarlinton, G P Anderson, M L HibbsThe etiology of asthma, a chronic inflammatory disorder of the airways, remains obscure, although T cells appear to be central disease mediators. Lyn tyrosine kinase has been implicated as both a facilitator and inhibitor of signaling pathways that play a role in allergic inflammation, although its role in asthma is unclear because Lyn is not expressed in T cells. We show in the present study that Lyn-/- mice develop a severe, persistent inflammatory asthma-like syndrome with lung eosinophilia, mast cell hyperdegranulation, intensified bronchospasm, hyper IgE, and Th2-polarizing dendritic cells. Dendritic cells from Lyn-/- mice have a more immature phenotype, exhibit defective inhibitory signaling pathways, produce less IL-12, and can transfer disease when adoptively transferred into wild-type recipients. Our results show that Lyn regulates the intensity and duration of multiple asthmatic traits and indicate that Lyn is an important negative regulator of Th2 immune responses. Copyright © 2005 by The American Association of Immunologists, Inc.
History
Journal
Journal of ImmunologyVolume
175Issue
3Pagination
1867 - 1875Publisher DOI
ISSN
0022-1767Usage metrics
Categories
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC